It was a busy week for the Contemporary OB/GYN® team.
This week's top articles included:
On Aug. 23, the U.S. Food and Drug Administration granted full approval to the Pfizer-BioNTech coronavirus vaccine, which is a significant milestone in the pandemic. It is the first licensing of a vaccine for the novel coronavirus.
The role of the community pharmacist has greatly expanded beyond traditional product-focused services to encompass a number of sexual and reproductive health (SRH) services, according to a review in BMJ Open.
A high-throughput molecular diagnostic system that is fully automated has won approval from the U.S. Food and Drug Administration and now is available in the U.S. market for cervical cancer screenings.
Alcohol and tobacco use throughout the first trimester of pregnancy was associated with nearly 3 times the risk of late stillbirth (at 28 or more weeks), compared to women who neither drank alcohol nor smoked during pregnancy or quit both before the end of the first trimester.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More